This report studies the global market size of Therapeutic Enzymes in key regions like North America and Europe., focuses on the consumption of Therapeutic Enzymes in these regions.
This research report categorizes the global Therapeutic Enzymes market by top players/brands, region, type and end user. This report also studies the global Therapeutic Enzymes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care
Leadiant Biosciences
Therapeutic Enzymes market size by Type
Injectable
Oral
Topical
Oral had the biggest market share of 94% in 2018.
Therapeutic Enzymes market size by Applications
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others
MPS Disease is the greatest segment of Therapeutic Enzymes application, with a share of 22% in 2018.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Therapeutic Enzymes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Therapeutic Enzymes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Therapeutic Enzymes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Therapeutic Enzymes submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Therapeutic Enzymes are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Therapeutic Enzymes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
This research report categorizes the global Therapeutic Enzymes market by top players/brands, region, type and end user. This report also studies the global Therapeutic Enzymes market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi
BioMarin
AbbVie
Shire
Alexion
Horizon Pharma
Allergan
Johnson & Johnson
Recordati Rare Diseases
Pfizer
Vivus
Digestive Care
Leadiant Biosciences
Therapeutic Enzymes market size by Type
Injectable
Oral
Topical
Oral had the biggest market share of 94% in 2018.
Therapeutic Enzymes market size by Applications
Gaucher Disease
MPS Disease
Gastrointestinal Diseases
Others
MPS Disease is the greatest segment of Therapeutic Enzymes application, with a share of 22% in 2018.
Market size by Region
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Therapeutic Enzymes market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Therapeutic Enzymes market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Therapeutic Enzymes companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Therapeutic Enzymes submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Therapeutic Enzymes are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Therapeutic Enzymes market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Therapeutic Enzymes Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Therapeutic Enzymes Market Size Growth Rate by Type
1.4.2 Injectable
1.4.3 Oral
1.4.4 Topical
1.5 Market by Application
1.5.1 Global Therapeutic Enzymes Market Size Growth Rate by Application
1.5.2 Gaucher Disease
1.5.3 MPS Disease
1.5.4 Gastrointestinal Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Therapeutic Enzymes Market Size
2.1.1 Global Therapeutic Enzymes Revenue 2014-2025
2.1.2 Global Therapeutic Enzymes Sales 2014-2025
2.2 Therapeutic Enzymes Growth Rate by Regions
2.2.1 Global Therapeutic Enzymes Sales by Regions
2.2.2 Global Therapeutic Enzymes Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Therapeutic Enzymes Sales by Manufacturers
3.1.1 Therapeutic Enzymes Sales by Manufacturers
3.1.2 Therapeutic Enzymes Sales Market Share by Manufacturers
3.2 Therapeutic Enzymes Revenue by Manufacturers
3.2.1 Therapeutic Enzymes Revenue by Manufacturers (2014-2019)
3.2.2 Therapeutic Enzymes Revenue Share by Manufacturers (2014-2019)
3.3 Therapeutic Enzymes Price by Manufacturers
3.4 Therapeutic Enzymes Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Enzymes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Enzymes Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Enzymes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Therapeutic Enzymes Sales by Type
4.2 Global Therapeutic Enzymes Revenue by Type
4.3 Therapeutic Enzymes Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Therapeutic Enzymes Breakdown Data by Application
6 North America
6.1 North America Therapeutic Enzymes by Country
6.1.1 North America Therapeutic Enzymes Sales by Country
6.1.2 North America Therapeutic Enzymes Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Therapeutic Enzymes by Type
6.3 North America Therapeutic Enzymes by Application
7 Europe
7.1 Europe Therapeutic Enzymes by Country
7.1.1 Europe Therapeutic Enzymes Sales by Country
7.1.2 Europe Therapeutic Enzymes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Enzymes by Type
7.3 Europe Therapeutic Enzymes by Application
8 Asia Pacific
8.1 Asia Pacific Therapeutic Enzymes by Region
8.1.1 Asia Pacific Therapeutic Enzymes Sales by Region
8.1.2 Asia Pacific Therapeutic Enzymes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Therapeutic Enzymes by Type
8.3 Asia Pacific Therapeutic Enzymes by Application
9 Central & South America
9.1 Central & South America Therapeutic Enzymes by Country
9.1.1 Central & South America Therapeutic Enzymes Sales by Country
9.1.2 Central & South America Therapeutic Enzymes Revenue by Country
9.1.3 Brazil
9.2 Central & South America Therapeutic Enzymes by Type
9.3 Central & South America Therapeutic Enzymes by Application
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Enzymes by Country
10.1.1 Middle East and Africa Therapeutic Enzymes Sales by Country
10.1.2 Middle East and Africa Therapeutic Enzymes Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Therapeutic Enzymes by Type
10.3 Middle East and Africa Therapeutic Enzymes by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi Therapeutic Enzymes Products Offered
11.1.5 Sanofi Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Details
11.2.2 Company Business Overview
11.2.3 BioMarin Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.2.4 BioMarin Therapeutic Enzymes Products Offered
11.2.5 BioMarin Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 Company Business Overview
11.3.3 AbbVie Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AbbVie Therapeutic Enzymes Products Offered
11.3.5 AbbVie Recent Development
11.4 Shire
11.4.1 Shire Company Details
11.4.2 Company Business Overview
11.4.3 Shire Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Shire Therapeutic Enzymes Products Offered
11.4.5 Shire Recent Development
11.5 Alexion
11.5.1 Alexion Company Details
11.5.2 Company Business Overview
11.5.3 Alexion Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Alexion Therapeutic Enzymes Products Offered
11.5.5 Alexion Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Horizon Pharma Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Horizon Pharma Therapeutic Enzymes Products Offered
11.6.5 Horizon Pharma Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Company Business Overview
11.7.3 Allergan Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Allergan Therapeutic Enzymes Products Offered
11.7.5 Allergan Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Company Business Overview
11.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Johnson & Johnson Therapeutic Enzymes Products Offered
11.8.5 Johnson & Johnson Recent Development
11.9 Recordati Rare Diseases
11.9.1 Recordati Rare Diseases Company Details
11.9.2 Company Business Overview
11.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Recordati Rare Diseases Therapeutic Enzymes Products Offered
11.9.5 Recordati Rare Diseases Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Business Overview
11.10.3 Pfizer Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Pfizer Therapeutic Enzymes Products Offered
11.10.5 Pfizer Recent Development
11.11 Vivus
11.12 Digestive Care
11.13 Leadiant Biosciences
12 Future Forecast
12.1 Therapeutic Enzymes Market Forecast by Regions
12.1.1 Global Therapeutic Enzymes Sales Forecast by Regions 2019-2025
12.1.2 Global Therapeutic Enzymes Revenue Forecast by Regions 2019-2025
12.2 Therapeutic Enzymes Market Forecast by Type
12.2.1 Global Therapeutic Enzymes Sales Forecast by Type 2019-2025
12.2.2 Global Therapeutic Enzymes Revenue Forecast by Type 2019-2025
12.3 Therapeutic Enzymes Market Forecast by Application
12.4 North America Therapeutic Enzymes Forecast
12.5 Europe Therapeutic Enzymes Forecast
12.6 Asia Pacific Therapeutic Enzymes Forecast
12.7 Central & South America Therapeutic Enzymes Forecast
12.8 Middle East and Africa Therapeutic Enzymes Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Therapeutic Enzymes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1 Study Coverage
1.1 Therapeutic Enzymes Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Therapeutic Enzymes Market Size Growth Rate by Type
1.4.2 Injectable
1.4.3 Oral
1.4.4 Topical
1.5 Market by Application
1.5.1 Global Therapeutic Enzymes Market Size Growth Rate by Application
1.5.2 Gaucher Disease
1.5.3 MPS Disease
1.5.4 Gastrointestinal Diseases
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Therapeutic Enzymes Market Size
2.1.1 Global Therapeutic Enzymes Revenue 2014-2025
2.1.2 Global Therapeutic Enzymes Sales 2014-2025
2.2 Therapeutic Enzymes Growth Rate by Regions
2.2.1 Global Therapeutic Enzymes Sales by Regions
2.2.2 Global Therapeutic Enzymes Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Therapeutic Enzymes Sales by Manufacturers
3.1.1 Therapeutic Enzymes Sales by Manufacturers
3.1.2 Therapeutic Enzymes Sales Market Share by Manufacturers
3.2 Therapeutic Enzymes Revenue by Manufacturers
3.2.1 Therapeutic Enzymes Revenue by Manufacturers (2014-2019)
3.2.2 Therapeutic Enzymes Revenue Share by Manufacturers (2014-2019)
3.3 Therapeutic Enzymes Price by Manufacturers
3.4 Therapeutic Enzymes Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Enzymes Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Enzymes Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Enzymes Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Therapeutic Enzymes Sales by Type
4.2 Global Therapeutic Enzymes Revenue by Type
4.3 Therapeutic Enzymes Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Therapeutic Enzymes Breakdown Data by Application
6 North America
6.1 North America Therapeutic Enzymes by Country
6.1.1 North America Therapeutic Enzymes Sales by Country
6.1.2 North America Therapeutic Enzymes Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Therapeutic Enzymes by Type
6.3 North America Therapeutic Enzymes by Application
7 Europe
7.1 Europe Therapeutic Enzymes by Country
7.1.1 Europe Therapeutic Enzymes Sales by Country
7.1.2 Europe Therapeutic Enzymes Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Enzymes by Type
7.3 Europe Therapeutic Enzymes by Application
8 Asia Pacific
8.1 Asia Pacific Therapeutic Enzymes by Region
8.1.1 Asia Pacific Therapeutic Enzymes Sales by Region
8.1.2 Asia Pacific Therapeutic Enzymes Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific Therapeutic Enzymes by Type
8.3 Asia Pacific Therapeutic Enzymes by Application
9 Central & South America
9.1 Central & South America Therapeutic Enzymes by Country
9.1.1 Central & South America Therapeutic Enzymes Sales by Country
9.1.2 Central & South America Therapeutic Enzymes Revenue by Country
9.1.3 Brazil
9.2 Central & South America Therapeutic Enzymes by Type
9.3 Central & South America Therapeutic Enzymes by Application
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Enzymes by Country
10.1.1 Middle East and Africa Therapeutic Enzymes Sales by Country
10.1.2 Middle East and Africa Therapeutic Enzymes Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Therapeutic Enzymes by Type
10.3 Middle East and Africa Therapeutic Enzymes by Application
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi Therapeutic Enzymes Products Offered
11.1.5 Sanofi Recent Development
11.2 BioMarin
11.2.1 BioMarin Company Details
11.2.2 Company Business Overview
11.2.3 BioMarin Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.2.4 BioMarin Therapeutic Enzymes Products Offered
11.2.5 BioMarin Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Details
11.3.2 Company Business Overview
11.3.3 AbbVie Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.3.4 AbbVie Therapeutic Enzymes Products Offered
11.3.5 AbbVie Recent Development
11.4 Shire
11.4.1 Shire Company Details
11.4.2 Company Business Overview
11.4.3 Shire Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Shire Therapeutic Enzymes Products Offered
11.4.5 Shire Recent Development
11.5 Alexion
11.5.1 Alexion Company Details
11.5.2 Company Business Overview
11.5.3 Alexion Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Alexion Therapeutic Enzymes Products Offered
11.5.5 Alexion Recent Development
11.6 Horizon Pharma
11.6.1 Horizon Pharma Company Details
11.6.2 Company Business Overview
11.6.3 Horizon Pharma Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Horizon Pharma Therapeutic Enzymes Products Offered
11.6.5 Horizon Pharma Recent Development
11.7 Allergan
11.7.1 Allergan Company Details
11.7.2 Company Business Overview
11.7.3 Allergan Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Allergan Therapeutic Enzymes Products Offered
11.7.5 Allergan Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Details
11.8.2 Company Business Overview
11.8.3 Johnson & Johnson Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Johnson & Johnson Therapeutic Enzymes Products Offered
11.8.5 Johnson & Johnson Recent Development
11.9 Recordati Rare Diseases
11.9.1 Recordati Rare Diseases Company Details
11.9.2 Company Business Overview
11.9.3 Recordati Rare Diseases Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Recordati Rare Diseases Therapeutic Enzymes Products Offered
11.9.5 Recordati Rare Diseases Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Company Business Overview
11.10.3 Pfizer Therapeutic Enzymes Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Pfizer Therapeutic Enzymes Products Offered
11.10.5 Pfizer Recent Development
11.11 Vivus
11.12 Digestive Care
11.13 Leadiant Biosciences
12 Future Forecast
12.1 Therapeutic Enzymes Market Forecast by Regions
12.1.1 Global Therapeutic Enzymes Sales Forecast by Regions 2019-2025
12.1.2 Global Therapeutic Enzymes Revenue Forecast by Regions 2019-2025
12.2 Therapeutic Enzymes Market Forecast by Type
12.2.1 Global Therapeutic Enzymes Sales Forecast by Type 2019-2025
12.2.2 Global Therapeutic Enzymes Revenue Forecast by Type 2019-2025
12.3 Therapeutic Enzymes Market Forecast by Application
12.4 North America Therapeutic Enzymes Forecast
12.5 Europe Therapeutic Enzymes Forecast
12.6 Asia Pacific Therapeutic Enzymes Forecast
12.7 Central & South America Therapeutic Enzymes Forecast
12.8 Middle East and Africa Therapeutic Enzymes Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Therapeutic Enzymes Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
